Back to Journals » Diabetes, Metabolic Syndrome and Obesity » Volume 12

Short-term efficacy and safety of repaglinide versus glimepiride as augmentation of metformin in treating patients with type 2 diabetes mellitus

Total article views   HTML views PDF downloads Totals
9,373 Dovepress* 8,072+ 1,620 9,692
PubMed Central* 1,301 180 1,481
Totals 9,373 1,800 11,173
*Since 17 April 2019

View citations on PubMed and Google Scholar